APEIRON Biologics
Show contact
Ulrich Granzer has a wide range of experience in all aspects of drug development and regulatory affairs, including drug safety and GXP.
Mag Rainer C. Burian
Supervisory Board Member
Josef Penninger
Erwin Rasinger
Helmut Schuehsler
Daniel D. Von Hoff
Advisor
Ruth Ladenstein
Hans Loibner
Anthony El-Khoueiry
+ 7 more
16 members
Current role
Ulrich Granzer